U.S. Oncology Research, The Woodlands, TX, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Unità di Ginecologia Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori and MITO, Milan, Italy, Gynecologic Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, Gynaecologic Cancer Programme, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain, Department of Oncology, St John of God Subiaco Hospital, Subiaco, Western Australia, Australia, Gynecologic Cancer Program, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy, Division of Gynecologic Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada, Department of Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom, Gynecologic Oncology, Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore Roma, Rome, Italy, Gynecological Unit, Gustave Roussy Cancer Center, INSERM U981; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Villejuif, France, Department of Gynecologic Oncology, Florida Hospital Cancer Institute, Orlando, FL, Medical Oncology Department, Oncology Center of Galicia, La Coruña, Spain, Medical Oncology Department, Auckland City Hospital, Grafton, Auckland, New Zealand, Department of Oncology, Cancer Care Services, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia, and University of Queensland, St. Lucia, QLD, Australia, Clinical Research Gynecologic Oncology, The Ohio State University, James Cancer Center, Columbus, OH, Biostatistics, Clovis Oncology, Inc., Boulder, CO, Clinical Development, Clovis Oncology, Inc., Boulder, CO, Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, United Kingdom